The most common keywords used in the research papers are semaglutide, obesity, T2DM, GLP-1, GLP-1 RA, antidiabetic agent, liraglutide, and cardiovascular disease. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.